Skip to Content

Ragwitek Approval History

  • FDA approved: Yes (First approved April 17th, 2014)
  • Brand name: Ragwitek
  • Generic name: ragweed pollen allergen extract
  • Company: Merck & Co., Inc.
  • Treatment for: Allergic Rhinitis

Ragwitek (short ragweed pollen allergen extract) is a sublingual immunotherapy for the treatment of ragweed allergies.

Development History and FDA Approval Process for Ragwitek

Apr 17, 2014Approval FDA Approves Ragwitek for Short Ragweed Pollen Allergies
Jan 28, 2014Merck Statement on FDA Advisory Committee Meeting for Ragwitek™ (Short Ragweed Pollen Allergen Extract), an Investigational Sublingual Allergy Immunotherapy Tablet

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.